Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors

被引：17
|
作者：
Chandarlapaty, Sarat [1 ]
Razavi, Pedram [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 14期
关键词：
COMPREHENSIVE MOLECULAR PORTRAITS; MUTATIONS; PALBOCICLIB; LANDSCAPE; THERAPY; ABEMACICLIB; FULVESTRANT;
D O I：
10.1200/JCO.19.00090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1148 / +
页数：4
相关论文
共 50 条
  • [1] Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
    Graf, F.
    Mosch, B.
    Koehler, L.
    Bergmann, R.
    Wuest, F.
    Pietzsch, J.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 527 - 539
  • [2] Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences
    Johnston, Stephen
    Emde, Anna
    Barrios, Carlos
    Srock, Stefanie
    Neven, Patrick
    Martin, Miguel
    Cameron, David
    Janni, Wolfgang
    Gnant, Michael
    [J]. JNCI CANCER SPECTRUM, 2023, 7 (04)
  • [3] Novel ATP-site cyclin-dependent kinase (CDK) inhibitors: Selective inhibitors of CDK4/cyclin D.
    Li, L
    Chong, WKM
    Duvadie, RK
    Chu, SS
    Yang, YM
    Nonomiya, J
    Tucker, KD
    Lewis, CT
    Knighton, DR
    Ferre, RA
    Lundgren, K
    Koudriakova, T
    Escobar, J
    Price, SM
    Huber, A
    Sisson, W
    Aust, RM
    Verkhivker, GM
    Schaffer, L
    Rose, PW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U985 - U986
  • [4] Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors
    Koehler, Lena
    Graf, Franziska
    Bergmann, Ralf
    Steinbach, Joerg
    Pietzsch, Jens
    Wuest, Frank
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) : 727 - 737
  • [5] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    [J]. MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [6] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    [J]. Molecular Biotechnology, 2001, 19 : 179 - 188
  • [7] Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
    Ryohei Ogata
    Emi Kishino
    Wataru Saitoh
    Yoshikazu Koike
    Junichi Kurebayashi
    [J]. Breast Cancer, 2021, 28 (1) : 206 - 215
  • [8] Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
    Ogata, Ryohei
    Kishino, Emi
    Saitoh, Wataru
    Koike, Yoshikazu
    Kurebayashi, Junichi
    [J]. BREAST CANCER, 2021, 28 (01) : 206 - 215
  • [9] Impact of Cyclin-Dependent Kinase CDK4 Inhibition on Eryptosis
    Lang, Elisabeth
    Zelenak, Christine
    Eberhard, Matthias
    Bissinger, Rosi
    Rotte, Anand
    Ghashghaeinia, Mehrdad
    Lupescu, Adrian
    Lang, Florian
    Qadri, Syed M.
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (03) : 1178 - 1186
  • [10] Structure-activity relationships (SAR) for human cyclin-dependent kinase 4 (CDK4)/cyclin D with hovel CDK inhibitors using a CDK4 homology model.
    Schaffer, L
    Rose, PW
    Chong, WKM
    Li, L
    Duvadie, RK
    Nonomiya, J
    Knighton, DR
    Ferre, R
    Yang, YM
    Chu, SS
    Tucker, KD
    Sisson, W
    Aust, RM
    Lewis, CT
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U530 - U530
12345